HSF1 and neoplasm: Intriguingly, the miR-644a-HSF1 axis triggers the onset of the apoptotic pathway whereas the LIMIT-GBP-HSF1 axis impacts immunotherapy - both attenuating tumor progression by suppression or stimulation of HSF1, respectively.